**Dr. Larry Corey** is an internationally renowned expert in virology, immunology and vaccine development, and the former president and director of Fred Hutch Cancer Center. His research focuses on herpes viruses, HIV, the novel coronavirus and other viral infections, including those associated with cancer. For 25 years Dr. Corey has led the HIV Vaccine Trials Network, the largest international research network focused on developing a safe and effective vaccine against HIV. In 2020 he was selected by Dr. Anthony Fauci to lead the CoVID Prevention Network to run the clinical trials for COVID-19 under Operation Warpspeed. The scientific work on HIV made it possible to achieve a COVID vaccine in record time. In turn, COVID vaccines gave us mRNA technologies and the ability to speed up vaccine development and save more lives.

**Sally Bock** A philosopher at heart and a multi-faceted strategist by practice, I enjoy bringing clarity to ambiguity, and delving into the space between culture and story to distill complex ideas into simple terms. As a creative leader and multistrategist I help brands large and small create meaning, connect emotionally and elevate their stories. My expertise in brand strategy, storytelling and creative campaigns stretches across technology, health care, consumer, social good, education, and arts and culture.
Currently at Fred Hutch Cancer Center I lead communications strategies for the HIV Vaccine Trials Network's global clinical trials, making sure science feels human. In 2020, I guided the marketing effort to support the COVID-19 vaccine Phase 3 trials, engaging 700,000+ volunteers within six months through multicultural campaigns across the U.S., South Africa, Brazil, and Peru.

**Mitchell Warren** has served as the Executive Director of AVAC since 2004, leading the organization’s strategic direction and partnerships across global HIV prevention and research. Under his leadership, AVAC expanded from HIV vaccine advocacy to a broader focus on biomedical prevention options and product access.
Warren is co-chair of the Global HIV Prevention Coalition; member of PEPFAR’s Scientific Advisory Board) and the International AIDS Society (IAS) Governing Council; President of the TB Alliance Stakeholder Association; and Past President of the Global HIV Vaccine Enterprise.
Previously, he served as Senior Director for Vaccine Preparedness at the International AIDS Vaccine Initiative (IAVI); Vice President of International Affairs for The Female Health Company (FHC); and at Population Services International (PSI) designing and implementing social marketing, communications and health promotion activities, including five years running PSI’s project in South Africa.

**Steven Wakefield** Retiree and the former Director of External Relations at the HIV Vaccine Trials Network (HVTN), cultivated and spearheaded strategic partnerships with organizations and stakeholders across the globe.
Wakefield, as he is known by his colleagues, advocates for the needs of underrepresented, underserved populations in medical research. He is proud of his contributions to Test Positive Aware Network (TPAN), AVAC and various committees such as the National Institute of Allergy and Infectious Diseases (NIAID) AIDS Vaccine Research Subcommittee.

**Mark Harrington** Today Mark Harrington is Execuitive Director of the Treatment Action Group. He joined the seminal AIDS activist group, ACT UP (the AIDS Coalition to Unleash Power) in 1988, five years after receiving his bachelor’s degree from Harvard University. As a member of ACT UP’s Treatment and Data Committee, Mark helped plan and execute ACT UP’s “Seize Control of the FDA” demonstration in 1988 and its “Storm the NIH” demonstration in 1990. The events helped initiate a fundamental shift in regard to how the U.S. Food and Drug Administration (FDA), the U.S. National Institutes of Health (NIH), and other government agencies addressed HIV community health priorities.
Mark wrote and edited many reports for ACT UP, including three editions of the National AIDS Treatment Research Agenda (1989–91). He was a founding member of the US AIDS Clinical Trials Group (ACTG) Community Constituency Group, serving from 1990 to 1993 on the ACTG Opportunistic Infections and Primary Infection Committees.
In 1992, Mark and 20 other AIDS activists cofounded the Treatment Action Group (TAG). The group scored its first major victory when a groundbreaking report he coauthored with Gregg Gonsalves, AIDS Research at the NIH: A Critical Review (1992), led to federal legislation restructuring the NIH AIDS research effort and strengthening the NIH Office of AIDS Research, signed into law by President Bill Clinton in June 1993.
At the Eighth International AIDS Conference in Amsterdam in July 1992, Mark delivered a plenary address entitled “Pathogenesis and Activism,” using slides of his own HIV-infected lymph nodes to illustrate critically important unanswered questions about the basic science of HIV infection. In 1993, he wrote The Crisis in Clinical AIDS Research, an exposé of inadequate clinical trials then being carried out by the ACTG, the U.S. Department of Defense, and others.
Mark edited and cowrote two TAG reports that were influential in the development of HIV protease inhibitors: Rescuing Accelerated Approval: Moving Beyond the Status Quo (1994) and Problems with Protease Inhibitor Development Plans (1995). He served as an ad hoc community representative at several meetings of the FDA Antiviral Drugs Advisory Committee, and also served on the NIH AIDS Research Program Evaluation Working Group (the Levine Committee), whose 1996 report called for sweeping restructuring of the NIH AIDS research program.
Mark received a MacArthur Foundation Fellowship in 1997, and that same year he became TAG’s senior policy director. In 1998 he delivered a plenary speech, “Cure: Myth or Reality?” at the Twelfth World AIDS Conference in Geneva, where he showed the impact of progressive HIV infection on one of his lymph nodes, and the impact of antiretroviral therapy; he called for studies on when to start antiretroviral therapy, and for massively increased treatment access in developing countries.
In 1999, Mark helped organize the first of three Structured Treatment Interruption Workshops cosponsored by TAG, the Foundation for AIDS and Immune Research, and Project Inform. He served on the U.S. Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents from 1996 to 2008. He is a member of the writing group that produces and updates the World Health Organization (WHO) Guidelines for Antiretroviral Therapy for HIV Infection in Resource-Limited Settings, and is a member of the WHO advisory groups for tuberculosis (TB) and for HIV, and of the Stop TB Partnership’s Global TB/HIV Working Group and its Multidrug Resistant (MDR)-TB Working Group.
Mark has coauthored papers published in the Lancet, PloS Medicine, and Science.
Pronouns: he/him/his

**Guido Rutenberg** is an audiovisual producer with extensive experience in the advertising, film, and communication industries. Trained in post-production, he began his career in advertising as a digital compositor and editor. After a brief period as a film director, he fully dedicated himself to executive production and to leading his own production company, Mu Films, from where he has driven the development and execution of campaigns for major global brands.
With a creative vision and strong management skills, Guido has led projects ranging from television commercials and digital content to documentaries and institutional communication pieces. His style is distinguished by the combination of narrative sensitivity and efficiency in team and resource organization, achieving high-impact results both artistically and strategically.
Since the 2020 pandemic, he has embraced a collaborative working model that led him to develop, among other projects, commercials and outreach pieces for the HVTN (HIV Vaccine Trials Network). Within this framework, a highlight is his role as one of the executive producers of the documentary HVTN: The Journey to an HIV Vaccine, a work featured in this festival.
Throughout his career, he has collaborated with production companies, agencies, and international organizations, building a network that positions him as a reliable reference within the audiovisual sector. He is currently developing projects that integrate innovation, storytelling, and technology with the aim of connecting brands and audiences through relevant and memorable stories.

**Norberto -Norbi- Zylberberg** is a creative leader and storyteller with a career built on crafting narratives that connect with audiences in meaningful, emotionally resonant ways. Originally from Argentina and living in Austin for 23 years, he began his journey in advertising with a master-level degree in copywriting and marketing, and over the years he's written commercials, developed award-winning campaigns, and directed short films—all with a focus on concise, impactful storytelling. His work has been recognized at Cannes, Clio, and other international festivals, reflecting a commitment to stories that not only sell but also entertain and inspire.
Throughout his career, Norbi specialized in bringing clarity and emotion to short-form narratives, from commercials to branded content, while also expanding into long-form projects that demand a deeper social sensibility. One of the most meaningful opportunities was contributing to the documentary HVTN: The journey for an HIV Vaccine, where the challenge was to humanize complex science through authentic, empathetic storytelling. Whether in thirty seconds or seventy two minutes, his approach remains the same: uncover the truth at the core of a message and shape it into a story that moves people.
To complement this creative practice, Norbi has pursued ongoing studies in leadership, user experience, social media, and diversity and inclusion at institutions including VCU, the Berlin School of Creative Leadership, Georgetown, UCSF, and Cornell. This blend of craft, curiosity, and cultural awareness generated at his agency - Socialisssima - continues to inform his work—helping brands, nonprofits, and film projects alike connect with audiences through stories that are both relevant and real.

**Matias Trachter** Mati graduated as a Film Director from the Universidad del Cine in Buenos Aires in the early 2000s. He built a solid career in the advertising industry, directing campaigns for global brands such as Renault, Fiat, L’Oréal, Tigo, Movistar, Meta, YPF, and Logytech.
Known for his narrative vision and sensitivity as a storyteller, he has created short documentaries exploring subjects as diverse as sports, industry, and technology, always with empathy and audience impact at the core. His first feature-length documentary, HVTN: The Journey for an HIV Vaccine, marked his debut in long-form filmmaking and reaffirmed his interest in projects with a strong social and human dimension.
He is currently developing new original fiction and documentary projects that aim to connect with audiences through authentic and emotionally resonant storytelling.

**Kira Dineen**, MS, LCGC, CG(ASCP)CM (she/her) is a multi-award winning podcaster with over a decade of experience producing/hosting. She is the Founder and CEO of Gene Pool Media, the science podcast network housing shows including her own *DNA Today*. With over 350 episodes and 80 sponsors, DNA Today has established itself as a leading voice in genetics. Kira is also a certified licensed genetic counselor at a high risk pregnancy practice.

**Susan Lee Kim - Corporate Secretary, Live Event Co-Producer**
Susan Kim is the Corporate Secretary of Raw Science Film Festival, Inc. She is a seasoned attorney who has worked for multiple financial services institutions, including a large institutional bank and a company which provides CFO services to venture-backed start-ups. She was most recently Vice President and Deputy General Counsel for an alternative financing company and has served on the boards of multiple non-profit organizations. Susan is a graduate of the University of Chicago Law School and earned her undergraduate degree in Economics-Philosophy from Columbia University in three years.

**Josh Chamot - Communications Volunteer**
Josh Chamot recently stepped away from his role as Media Officer for Artificial Intelligence at the U.S. National Science Foundation, where he collaborated with scientists and engineers, reporters, industry partners, and other agencies to break news about research and inspire public engagement. Across two decades at NSF, he promoted nearly every field of research--from quantum computing to paleontology, from particle physics to cancer treatment--through press briefings and public outreach, social media and feature content, oversight of video and animation products, expert trainings, and more.

Keri Kukral - Festival Founder, Executive Producer

Keri Kukral (founder) is a former professional ballet dancer and was awarded a full scholarship to the Ruth Page Foundation after being hand selected by Ruth Page from the Arie Crown Theater stage as a child. She has a degree in bio/ electrical engineering from Purdue University and a long career in the medical device industry most recently as Global Design Quality Engineering Manager at Celestica for drug-device combination products and electromechanical surgical instruments. Keri is the Founder and Executive Producer of the Raw Science Film Festival.